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Background: Up to 50% of chronic whiplash associated disorders (WAD) patients experience considerable pain and
disability and remain on sick-leave. No evidence supports the use of physiotherapy treatment of chronic WAD,
although exercise is recommended. Previous randomised controlled studies did not evaluate the value of adding a
behavioural therapy intervention to neck-specific exercises, nor did they compare these treatments to prescription
of general physical activity. Few exercise studies focus on patients with chronic WAD, and few have looked at
patients’ ability to return to work and the cost-effectiveness of treatments. Thus, there is a great need to develop
successful evidence-based rehabilitation models. The study aim is to investigate whether neck-specific exercise with
or without a behavioural approach (facilitated by a single caregiver per patient) improves functioning compared to
prescription of general physical activity for individuals with chronic WAD.
Methods/Design: The study is a prospective, randomised, controlled, multi-centre study with a 2-year follow-up
that includes 216 patients with chronic WAD (> 6 months and < 3 years). The patients (aged 18 to 63) must be
classified as WAD grade 2 or 3. Eligibility will be determined with a questionnaire, telephone interview and clinical
examination. The participants will be randomised into one of three treatments: (A) neck-specific exercise followed
by prescription of physical activity; (B) neck-specific exercise with a behavioural approach followed by prescription
of physical activity; or (C) prescription of physical activity alone without neck-specific exercises. Treatments will be
performed for 3 months. We will examine physical and psychological function, pain intensity, health care consumption,
the ability to resume work and economic health benefits. An independent, blinded investigator will perform the
measurements at baseline and 3, 6, 12 and 24 months after inclusion. The main study outcome will be improvement in
neck-specific disability as measured with the Neck Disability Index. All treatments will be recorded in treatment diaries
and medical records.
Discussion: The study findings will help improve the treatment of patients with chronic WAD.
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Whiplash associated disorders (WAD) are common [1-4],
with a cumulative annual incidence as high as 600 per 100
000 inhabitants [5]. When symptoms persist for more
than 6 months, WAD is considered chronic [6]. Recent
studies estimate that up to 50% of WAD patients experi-
ence prolonged symptoms, including considerable pain,
disability, sick leave and reduced income [7-9].
Due to the personal and societal burdens associated
with chronic WAD [1,2,9], it is extremely important to
determine the best possible treatment for reducing pain
and restoring the ability of patients to perform everyday
tasks and to return to work. A WAD diagnosis is based
on a patient’s subjective description of symptoms and
on clinical examination. The Quebec Task Force (QTF)
classified WAD into severity grades 0–4, with grade 0
indicating no neck complaints and no physical sign(s)
and grade 4 indicating a neck complaint with neck frac-
ture or dislocation [10]. Identifying subgroups in this
heterogeneous group of patients with chronic WAD
could lead to a better understanding of the complexity
of chronic WAD [11].
There is no consensus regarding the injury mechanism
in complex WAD cases. Some symptoms of persistent
WAD can be attributed to injuries involving neck struc-
tures, including joints, ligaments and muscles [12]. In
particular, WAD may involve an altered activation pat-
tern in the neck muscles [13]. Combinations of bio- and
psychosocial factors, such as fear of re-injury, low mood
and low self-efficacy, appear to affect recovery [14,15].
Thus, it is reasonable to assume that a combination
treatment that includes both a physical and a behav-
ioural approach might improve rehabilitative outcomes
[16]. However, it is time-consuming and costly to involve
several professionals in an individual’s treatment. Unfor-
tunately, little is known about how a single caregiver can
best use a combined physical and behavioural approach
to treat individuals with chronic WAD [16,17]. Specifically,
the effect of adding a behavioural component to neck-
specific exercises is unknown. Furthermore, few studies on
individuals with chronic WAD symptoms have investi-
gated the effects of exercises that specifically target neck
muscles.
Most studies of people with WAD have focused on the
acute phase. The general advice given to patients in this
phase of WAD is to be physically active [1,18]. There are
just a few randomised controlled trials (RCTs) of the ef-
fects on exercise on chronic WAD [14,15,19-21]. Of
these, two studies had small samples [15,19], and two
other studies [20,21] allowed the addition of passive
treatment strategies, making it difficult to determine the
effects of the different treatment components. Only one
larger RCT, conducted by Stewart et al. [14], included
patients with WAD grade 3 and compared a 6-weekexercise and behavioural programme to self-treatment
based on professional advice. Pain intensity, pain bother-
someness and function were used as primary outcome
measurements, and the short-term outcome favoured
professional advice in combination with exercise over
advice alone.
In all of the WAD RCTs to date, the effects of treat-
ment have been limited [17]. Unfortunately, there is a
lack of knowledge of how exercise regimens should be
designed to successfully treat chronic WAD [11]. No
evidence is available that supports physiotherapy treat-
ment of chronic WAD [17], although exercises are rec-
ommended [22]. There are no studies that compare the
effect of physical activity, which is commonly prescribed
[18], with other approaches, such as neck-specific exer-
cises or a behavioural intervention performed by a physio-
therapist. No studies have investigated the outcomes of
treatment in terms of the ability of patients to resume
work or the cost-effectiveness of different exercise pro-
grammes with or without behavioural therapy. Thus, there
is a great need for information about which rehabilitation
models are effective and cost-efficient.
The aim of this study is to investigate whether neck-
specific exercise with or without a behavioural component
(facilitated by a single caregiver per patient) improves func-
tioning compared to prescription of general physical activ-
ity for individuals with chronic WAD.
Methods/Design
Study population
The study will include 216 patients with WAD that has
lasted more than 6 months but less than 3 years. The in-
cluded patients will be randomised into one of the three
treatment arms.
Eligibility criteria
The inclusion criteria are: Age 18–63 years; WAD grade
2–3 after a whiplash injury at least six months but not
more than three years ago, QTF grade 2 includes neck
complaints and musculoskeletal sign(s), grade 3 includes
grade 2 plus neurological sign(s); Pain intensity > 20 mm
on a 100-mm Visual Analogue Scale (VAS) [23] and/or >
20% on the Neck Disability Index (NDI, 0–100%) [24].
Exclusion criteria are: Known or suspected serious
physical pathology, including myelopathy, spinal tumour,
spinal infection or ongoing malignancy; Earlier fracture
or luxation of the cervical column; Neck trauma with
persistent symptoms from previous injury; Surgery on
the cervical column; Neck pain that caused a > 1 month
absence from work in the year prior to the WAD trauma;
Signs of traumatic brain injury at the time of WAD (un-
consciousness, retrograde or post-traumatic amnesia, dis-
orientation or confusion); Generalised or more dominant
pain elsewhere in the body; Diseases or other injuries that
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a severe psychiatric disorder; Known drug abuse; Insuffi-
cient knowledge of the Swedish language (inability to an-
swer the questionnaires).
Design
This study is a prospective, randomised, controlled,
multi-centre study with a 2-year follow-up. Patients will
be recruited by searching electronic medical records in
five counties in Sweden. Individuals that sought care in
the previous 6 to 36 months due to WAD will receive
written information that describes the study and that
asks whether they are interested in participating. Inter-
ested individuals will be screened via questionnaires and
telephone interviews by an experienced physiotherapist
to determine eligibility and to provide standardised oral
information about the study (with a neutral description
of the treatment alternatives). Eligible individuals will be
asked to undergo a physical examination to ensure that
their symptoms are consistent with WAD grade 2 or 3.
After providing informed consent, eligible patients will
be included in the study. The estimated time period for
patient inclusion into the study is 2 years. Next, the pa-
tients will be randomised to receive one of three alterna-
tive physiotherapy treatments: (A) neck-specific exercise
followed by prescription of physical activity; (B) neck-
specific exercise with a behavioural approach followed
by prescription of physical activity; or (C) prescription of
physical activity alone without neck-specific exercises.
Treatment will be performed by physiotherapists in pri-
mary care centres or private outpatient clinics. The physio-
therapists will receive oral and written information about
the treatment programs and will participate in an educa-
tional session and practice the different interventions. All
treatments will be recorded in a diary and in medical
records.
Randomisation will be based on a computer-generated
list created by the university statistician. This list will as-
sign patient ID numbers to group A, B or C and will be
managed by an independent researcher who is not involved
in the study in any way. Data from the randomised individ-
uals will be distributed into sequentially numbered, sealed,
opaque envelopes. Each envelope will be sent to the treat-
ing physiotherapist (in primary care centres or at private
outpatient clinics) who will open the envelope and make
an appointment with the identified participant. Due to the
nature of the treatment, it will not be possible to blind the
physiotherapists or the participants to the treatment.
Outcome measurements
The measurements (clinical measurements and question-
naires) will be collected before treatment and 3, 6 and
12 months after inclusion. Questionnaires will also be col-
lected at a 24-month follow-up. Clinical (neck-related)measurements will be performed in a standardised man-
ner by a well-trained independent investigator who is
blinded to the randomisation procedure and who is not
involved in the interventions. Independent investigators
will also collect the questionnaires. The questionnaires will
ask about the patient’s background (including age, gender,
social status, education, smoking, pain duration, previous
treatment, information about the whiplash trauma and
other medical conditions), and about disease-specific in-
formation and generic data. The main treatment outcome
is neck-specific disability as measured with the NDI [24].
Clinical measurements
Clinical measurements includes: Neurological assessment:
sensibility, motor function, reflexes, Spurling’s test, neuro-
dynamic tests; Active range of motion of the neck in three
planes [25] and cervical kinaesthesia (the ability to repro-
duce the neutral head position from 30° cervical rotation
with the eyes closed) [26] as measured with a plastic hel-
met known as a “cervical range of motion device” [27];
Anterior and posterior neck muscle endurance in seconds
in a supine and prone position [28]; Isometric hand grip
strength as measured with the Jamar Hand Dynamometer
[29]; Static and dynamic clinical balance: static clinical bal-
ance as assessed with the Sharpened Romberg test, with
eyes closed and the non-dominant foot in front of the
dominant foot [30]; dynamic clinical balance as assessed
by the patient walking in a figure eight [31].
Questionnaires
Primary outcome measure is Neck-specific function: mea-
sured with the NDI [24].
Secondery outcome measures contained questionnaires
about: Neck pain intensity/ bothersomeness; Pain intensity
in the head and arm; Dizziness and unsteadiness: mea-
sured with a Visual Analogue Scale (VAS) (0–100 mm)
[23]; Domain-specific and general disability related to
chronic pain measured with the Pain Disability Index [32];
Dizziness: measured with the UCLA Dizziness Question-
naire [33]; Frequency of symptoms, including neck pain,
arm pain, headache, dizziness, visual disturbances, tinnitus,
difficulty swallowing and problems concentrating: mea-
sured with a 5-grade scale; Pain catastrophising: measured
with the Pain Catastrophising Scale [34]; Ability to perform
important activities, self-rated by the patient: measured
with the Patient-Specific Functional Scale and recorded by
the physiotherapist [35]; Confidence in the ability to per-
form different activities: measured with the Self-Efficacy
Scale [36]; Confidence in the ability to perform physical
training: measured with the Exercise Self-Efficacy Scale
[37]; Physical activity: estimated with the International
Physical Activity Questionnaire [38]; Operating fear: mea-
sured with the Tampa Scale of Kinesiophobia, short version
[39]; Depression and anxiety: measured with the Hospital
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of life: measured with the EuroQol-five dimension ques-
tionnaire [40], EuroQol thermometer (0–100) [41] and SF-
36 [42]; Work conditions, including type of work, work
ability and physical demands at work: measured with the
Work Ability Index [43]; work-related stress: measured
with the Effort Reward Imbalance at work [44]; work satis-
faction: measured with various specific questions; The
number of sick leave days and extent and disability pension
data (collected from the Swedish Social Insurance Agency),
the number of sick leave days is also answered on the ques-
tionnaire, health care consumption measured with ques-
tions about type of caregiver and number of visits.
Questionnaire to determine fulfilment and satisfaction
after treatment (to be filled in only after the treatment is
completed) are: Treatment success regarding the differ-
ence in function after treatment (on a 6-grade scale) and
the importance of the difference (0–100-mm VAS scale);
Fulfilment of treatment expectations (on a 3-point scale);
Satisfaction with the information and care provided mea-
sured with the Patient Enablement Instrument (PEI) [45]
and an open question.
Cost-effectiveness determination
Direct costs, mainly health care costs, including the
quantity and type of health care visits: determined from
questionnaires and from patient interviews. Indirect costs,
mainly production loss (i.e., inability to perform work due
to ill health). According to economic theory, production
loss is calculated as the gross income plus taxes for the
time period that the patient is absent from work. Sick-
leave compensation and income data will be collected
from the Social Insurance Office. The effectiveness of in-
terventions will be evaluated in terms of quality-adjusted
life years (QALYs). Cost-effectiveness will be evaluated by
comparing the costs and effects of the three interventions.
Interventions
All therapists will be required to keep records of the ex-
ercises performed, the behavioural interventions given
and the progress of each exercise in a diary.
Group A. Neck-specific exercise followed by prescrip-
tion of physical activity Neck-specific exercises will be
performed twice weekly at the physiotherapy clinic and
daily at home. The exercise therapy focuses on re-learning
motor skills, neck muscle endurance and postural correc-
tion. These exercises aim to increase coordination, endur-
ance and the strength of the muscles that stabilise the
neck and scapula. After the clinical examination, the expe-
rienced physiotherapist will design an exercise programme
from a well-defined set of exercises with a standardised,
structured progression plan. The physiotherapist will ad-
just the programme for each patient to ensure that theselection of exercise and dosages are appropriate for the
participant’s ability. The exercises will be performed daily
at home. The exercises are not supposed to cause pain.
After 3 months, the participant will receive a printed
individualized prescription for physical activity similar to
that provided to group C (see below), but which includes
neck-specific exercises. The aim is to encourage the pa-
tient to continue exercising to maintain and further im-
prove their functioning without depending on a therapist.
Group B. Neck-specific exercise with a behavioural
approach followed by prescription of physical activity
Each participant will undergo a three-month behavioural
approach in combination with neck-specific exercises; the
approach and exercise will be supervised by the physio-
therapist at the physiotherapy clinic (twice weekly). The
exercises are the same as those in group A, but with the
addition of a behavioural component. Patients will listen
to lectures about the basic neuroscience of pain. The
physiotherapist will help the participants set realistic and
specific activity goals, the aim of which is improvement of
daily function. The physiotherapist and patient will discuss
beliefs and barriers to recovery and methods for managing
symptom relapse. This aims to decrease fear/avoidance
and to increase self-efficacy and patient willingness to per-
form physical activity, despite the pain. It will also teach
the patient how to best deal with the pain and provide
greater understanding of the relationship between thoughts,
emotions, body function and WAD symptoms. Participants
will also be taught home exercises that focus on using relax-
ation to reduce stress and muscle tension and on postural
correction through body awareness techniques. Additional
home exercises (directed towards the participants’ activity
goals) will be performed as well. After 3 months, the par-
ticipant will receive a printed individualized prescription for
physical activity, including neck-specific exercises like those
provided to group A.
Group C. Prescription of physical activity alone Each
participant will have one or two appointments to complete
a physical examination and a short motivational interview
at the physiotherapy clinic. The interview will include de-
termining the patient’s willingness and motivation to adopt
new exercise routines and provide information about the
benefits of physical activity. The participant will receive a
printed copy of individualised, accessible, physical activity
instructions that do not include neck-specific exercise.
The aim of these activities is to increase the general level
of physical activity (i.e. to improve fitness and to elicit the
release of endorphins). The activity can be performed in a
selected location outside the healthcare environment, such
as in the home or at an athletic facility. The participant
will be allowed to phone the physiotherapist for further
advice regarding their physical activities if needed.
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This study will be conducted in accordance with the
declaration of Helsinki and with Swedish laws. The study
protocol has been approved by the Ethics Committee at
the Faculty of Health Sciences at Linköping University
in Sweden (2010/1888-31 and 2011/262-32). Written in-
formed consent will be obtained from all patients who
are included in the study. Patients will be free to leave
the study without explanation without any negative con-
sequences on future treatment.
There are no known risks associated with patient par-
ticipation in the study except for possible temporary
muscle aches after exercise. All physiotherapists involved
in the study must be registered at the National Board of
Health and Welfare in Sweden. All personal patient de-
tails will be made anonymous before data-entry. There
are no commercial interests tied to the study.
Statistical methods and power calculation
A sample-size calculation suggested that that 60 pa-
tients/group was necessary to detect a 7% change in the
NDI with a standard deviation for change of 13 with a
20% β-error (power 1- β = 080%) and an α-error of 0.05.
We added an extra 20% of the estimated number for
security, resulting in 72 patients/group and a total of 216
patients. Data will be analysed according to an intention-
to-treat approach. An alternative analysis will be per-
formed to take treatment compliance into consideration.
Analyses will be performed with parametric or non-
parametric statistics, depending on the type of data.
Time frame
The estimated time period for patient inclusion in the study
is 2 years. Follow-up will continue for another 2 years.
Discussion
This is a prospective randomized, controlled, multi-centre
trial with blinded assessors who are not involved in the
treatment. In order to provide treatment in the partici-
pants’ home towns, several physiotherapists will be in-
volved in the treatments. This is a disadvantage in that it
will result in decreased control of treatment performance;
however, all physiotherapists will undergo the same basic
training for the study and will be carefully instructed by
the project leaders. Both participants and physiotherapists
will keep treatment diaries. This is also an advantage in
that it will be possible to generalize the approach to pri-
mary health care conditions. Treatments will be individu-
ally tailored.
The Swedish Council on Technology Assessment in
Health Care has stated that there is a scientific gap in
knowledge in terms of the effects of exercise in adults with
chronic pain [46]. NHS Evidence from the UK Database of
Uncertainties about the Effects of Treatments (DUETs)has also identified both the effects of exercises for mechan-
ical neck disorders (including WAD) [47] and the effects
of conservative treatment for whiplash [48] to be impor-
tant gaps in scientific knowledge. This study will help fill
these gaps. The outcome of the study is expected to help
improve clinical decision-making for WAD patients. The
results will be directly applicable in clinical settings to im-
prove the treatment of patients with chronic WAD.
Conclusions
This study will provide practical knowledge about the ef-
fects of different exercise strategies on chronic WAD. It
will help improve treatment guidelines, which must take
into account both the patient’s physical and mental func-
tioning and the cost-effectiveness of different strategies.
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